![](/img/cover-not-exists.png)
Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
Bakish, David, Bose, Anjana, Gommoll, Carl, Chen, Changzheng, Nunez, Rene, Greenberg, William, Liebowitz, Michael, Khan, ArifVolume:
39
Language:
english
Journal:
Journal of Psychiatry & Neuroscience
DOI:
10.1503/jpn.130040
Date:
January, 2014
File:
PDF, 449 KB
english, 2014